logo

OVID

Ovid Therapeutics·NASDAQ
--
--(--)
--
--(--)

OVID fundamentals

Ovid Therapeutics (OVID) released its earnings on Aug 13, 2025: revenue was 6.27M (YoY +3611.24%), beat estimates; EPS was -0.06 (YoY -150.00%), beat estimates.
Revenue / YoY
6.27M
+3611.24%
EPS / YoY
-0.06
-150.00%
Report date
Aug 13, 2025
Earnings Call
7:00 AM on Aug 13, 2025
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

OVID has released its 2025 Q4 earnings report, with revenue of 718.00K, reflecting a YoY change of 844.74%, and net profit of 9.66M, showing a YoY change of 204.43%. The Sankey diagram below clearly presents OVID's revenue sources and cost distribution.

Key Indicators

Ovid Therapeutics (OVID) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Ovid Therapeutics (OVID)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Ovid Therapeutics (OVID)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Ovid Therapeutics (OVID)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Ovid Therapeutics (OVID) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Ovid Therapeutics (OVID) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield